Poster Abstract Session:
257. Vaccines: Varicella/Zoster
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Pediatric ID, Adult ID

Presentations:
Impact of Varicella Vaccination on hospitalization of the pediatric population in central Israel
Galia Grisaru-Soen, MD ; Meital Elbaz, MD ; Gideon Paret, MD ; Avihu Bar Yochai, MD ; Ora Halutz, MSc
Posters
  • Galia-p1 (3).pdf (127.4 kB)
  • Update on Incidence of Herpes Zoster among Children and Adolescents following implementation of Varicella Vaccination, Antelope Valley, California, 2000-2010
    Mona Marin, MD ; Rachel Civen, MD, MPH ; John Zhang, PhD ; Amanuel Abraham, MSc ; Rafael Harpaz, MD, MPH ; Laurene Mascola, MD, MPH ; Stephanie R. Bialek, MD, MPH
    Posters
  • Marin_Pediatric HZ_final.pdf (111.3 kB)
  • Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults by region: results of the phase 3 ZOE-50 trial
    Anthony L Cunningham, MB BS MD ; Roman Chlibek, MD Ph.D. ; Javier Diez-Domingo, Md Ph.D. ; Eugene Athan, MBBS, FRACP, MPH ; Jose-Fernando Barba-Gomez, MD ; Wayne Ghesquiere, MD FRCPC ; Shinn-Jang Hwang, MD ; Edward Leung, MD ; Myron Levin, MD, FIDSA ; Airi Poder, MD ; Joan Puig-Barbera, MD Ph.D. ; Jan Smetana, MD Ph.D. ; Timo Vesikari, MD, PhD ; Antonio Volpi, MD ; Olivier Godeaux, MD ; Toufik Zahaf, Ph.D. ; Himal Lal, MD ; Thomas Heineman, MD, PhD
    Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster
    Roger Baxter, MD, FIDSA ; Joan Bartlett, MPH, MPP ; Bruce Fireman, MA ; Morgan Marks, PhD ; John Hansen, MPH ; Ned Lewis, MPH ; Laurie Aukes, RN ; Yong Chen, PhD, MHS ; Patricia Saddier, MD, PhD
    Posters
  • 1928_IDWPoster.pdf (183.9 kB)
  • Declining herpes zoster vaccine effectiveness in adults 60 years and older
    Hung Fu Tseng, Ph.D., MPH ; Yi Luo, MS ; Craig Hales, MD, MS ; Stephanie R. Bialek, MD, MPH ; Rafael Harpaz, MD, MPH ; Sara Tartof, PhD, MPH ; Lina S. Sy, MPH ; Steven Jacobsen, MD, PhD
    Estimating the Potential Public Health Impact of Introducing the HZ/su Vaccine in the US Population Aged ≥50 Years
    Lijoy Varghese, MBA ; Desmond Curran, PhD ; Songkai Yan, M.S. ; Girishanthy Krishnarajah, Ph.D. ; Antonio Olivieri, MD
    Persistence of the Immune Response to an Adjuvanted Herpes Zoster Subunit Vaccine in Healthy Older Adults: Modeling of Vaccine-induced Immune Response, Data from a 6-year Follow-up Study
    Himal Lal, MD ; Roman Chlibek, MD, PhD ; Karlis Pauksens, MD, PhD ; Tino F. Schwarz, PhD ; Jan H. Richardus, MD, PhD ; Gini G.C. Van Rijckevorsel, MD, MSc, PhD ; Thomas C. Heineman, MD, PhD ; Grégory Catteau, MSc
    HCUP-based risk score for predicting herpes zoster
    Roger Baxter, MD, FIDSA ; Joan Bartlett, MPH, MPP ; Bruce Fireman, MA ; Yong Chen, PhD, MHS ; John Hansen, MPH ; Laurie Aukes, RN ; Ned Lewis, MPH ; Patricia Saddier, MD, PhD ; M. Alan Brookhart, PhD ; Morgan Marks, PhD ; Alec Walker, MD, DrPH ; Stefan Gravenstein, MD, MPH, CMD
    Posters
  • 1932_IDWPoster.pdf (488.4 kB)
  • Zoster Vaccine Coverage in a Privately Insured Population Aged ˇÝ50 Years in the United States from 2007 to 2013
    Dongmu Zhang, Ph.D. ; Kelly Johnson, PhD ; Chrisann Newransky, PhD ; Camilo Acosta, MD, PhD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.